PRDM14 Antibodies

Santa Cruz Biotechnology delivers a wide array of PRDM14 monoclonal antibodies for research focused on understanding this critical transcription factor. PRDM14 Antibodies are suitable for various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PRDM14 is a transcription factor that plays a significant role in the regulation of pluripotency and germ cell development. PRDM14 maintains the undifferentiated state of embryonic stem cells and has been implicated in various developmental processes and cancer biology. Understanding PRDM14 function is crucial for advancing research in stem cell biology and therapeutic applications. Researchers can utilize PRDM14 monoclonal antibodies to explore cellular mechanisms and pathways involved in development and disease progression. PRDM14 monoclonal antibodies enable detailed investigation of protein expression patterns and interactions in different cellular contexts. Advanced research techniques incorporating PRDM14 monoclonal antibodies help reveal new insights about stem cell regulation and cancer development. Santa Cruz Biotechnology monoclonal antibodies for PRDM14 support the scientific community in advancing our understanding of cellular development and disease mechanisms.